Kliničke studije za Limfom u državi Florida
25 studija za Limfom traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Moffit Cancer Center, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07015242Precise Oncology Interventions in Nutrition and Training (OnPoint)
- University of Miami, Miami
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06534918A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- University of Miami, Coral Gables
- Florida Cancer Specialists, Sarasota
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07221500AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Miami
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT06137144CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Johns Hopkins All Children's Hospital, St. Petersburg
U tijeku regrutacijaFaza 1/2
12 Months – 21 Years · Oba spola · Ažurirano 11. ruj 2026. · NCT04870944A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- AdventHealth Cancer Institute, Orlando
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06624085A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- University of Miami, Coral Gables
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06084936Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT04588922Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 13 do 90 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Mayo Clinic Florida, Jacksonville
- AdventHealth, Orlando
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Baptist Health Miami Cancer Institute, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT04792489A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Miami, Miami
- Florida Cancer Specialists, Sarasota
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT05131022CD4CAR for CD4+ Leukemia and Lymphoma
- University of Miami Sylvester Comprehensive Cancer Center, Miami
U tijeku regrutacijaFaza 1
Od 12 godina i više · Oba spola · Ažurirano 24. lip 2026. · NCT03829540A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site, Tampa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. lip 2026. · NCT05475925Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- University of Miami, Miami
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 1. lip 2026. · NCT05663502xDRIVE for Florida-based Cancer Patients
- First Ascent Biomedical, Miami
U tijeku regrutacija
Sve dobne skupine · Oba spola · Ažurirano 19. svi 2026. · NCT07167381Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Nemours Children's Clinic-Jacksonville, Jacksonville
- Nemours Children's Hospital, Orlando
- i još 2
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 18. svi 2026. · NCT01790152CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. tra 2026. · NCT03328078The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- ASCLEPES Research Centers, Weeki Wachee
U tijeku regrutacijaFaza 1/2
Od 12 do 95 godina · Oba spola · Ažurirano 15. tra 2026. · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Miami, Miami
U tijeku regrutacijaFaza 2
Od 18 do 66 godina · Oba spola · Ažurirano 17. ožu 2026. · NCT06859424A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
- University of Miami Sylvester Cancer Center, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. ožu 2026. · NCT05800366Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Sylvester Comprehensive Cancer Center, Miami
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 20. velj 2026. · NCT05745285A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
- Hematology-Oncology Associates of the Treasure Coast, Port Saint Lucie
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 4. velj 2026. · NCT05892718cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Miami Cancer Institute, Miami
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 godina i više · Oba spola · Ažurirano 20. sij 2026. · NCT05366881Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.